Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Chemical Communications (Cambridge, England)|November 20, 2020
Correction: Gold(I) complexes based on six-membered phosphorus heterocycles as bio-active molecules against brain cancerSaskia Roesch, Valentina Fermi, Frank Rominger, et al.
Chemical Communications (Cambridge, England)|October 30, 2020
Gold(i) complexes based on six-membered phosphorus heterocycles as bio-active molecules against brain cancerSaskia Roesch, Valentina Fermi, Frank Rominger, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|May 26, 2022
Luminescent Pyrrole-Based Phosphaphenalene Gold Complexes: Versatile Anticancer Tools with Wide ApplicabilityValentina Fermi, Elzbieta Regulska, Anna Wolfram, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 16, 2022
Luminescent Pyrrole-Based Phosphaphenalene Gold Complexes: Versatile Anticancer Tools with Wide ApplicabilityValentina Fermi, Elzbieta Regulska, Anna Wolfram, et al.
Neuroscience|November 5, 2016
Congenital prosopagnosia is associated with a genetic variation in the oxytocin receptor (OXTR) gene: An exploratory studyZaira Cattaneo, Roberta Daini, Manuela Malaspina, et al.
Acta Neuropathologica Communications|December 7, 2019
Single-nucleus chromatin accessibility reveals intratumoral epigenetic heterogeneity in IDH1 mutant gliomasRuslan Al-Ali, Katharina Bauer, Jong-Whi Park, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2023
Effective Reprogramming of Patient-Derived M2-Polarized Glioblastoma-Associated Microglia/Macrophages by Treatment with GW2580Valentina Fermi, Rolf Warta, Amélie Wöllner, et al.
NPJ Precision Oncology|June 16, 2026
Automated and personalized glioblastoma tumor organoid drug screening platform exposes sensitivity to proteasome and HDAC inhibitorsGerhard Jungwirth, Adrian Paul, Amélie Wöllner, et al.
Pageof 1